BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2894098)

  • 1. A case for palliative dermatology: COVID-19-related dermatoses.
    Ho B; Ray A
    Clin Dermatol; 2020; 38(6):768-769. PubMed ID: 33341213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
    Kurz K
    Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
    Honsinger RW; Thomsen RJ
    Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of astemizole. A survey of 50 double-blind trials.
    Vanden Bussche G; Emanuel MB; Rombaut N
    Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Astemizole in urticaria--a multicenter study by 412 established dermatologists].
    Kurz K; Oestreich W
    Z Hautkr; 1987 Dec; 62(24):1724-32. PubMed ID: 2894098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
    Emmi L; Rossi O
    Minerva Med; 1988 Mar; 79(3):219-27. PubMed ID: 2896316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of astemizole in the treatment of allergic rhinitis and urticaria: a systematic review with meta-analysis].
    Gutiérrez Castrellón P; Ramírez Mayans J; López Pérez G
    Rev Alerg Mex; 2005; 52(3):113-26. PubMed ID: 16158785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astemizole: a long-acting, nonsedating antihistamine.
    Krstenansky PM; Cluxton RJ
    Drug Intell Clin Pharm; 1987 Dec; 21(12):947-53. PubMed ID: 2892659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsedating H1 antihistamines in chronic urticaria.
    Monroe EW
    Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-sedative antihistaminics in the treatment of chronic urticaria].
    Negro JM; Sarrió F; Miralles JC; García Sellés FJ; López Sánchez JD; Pagán Ja; Hernándéz J
    Allergol Immunopathol (Madr); 1995; 23(3):137-44. PubMed ID: 7572544
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.